ShiraTronics
Healthcare & Life Sciences
Recent Finacing
Series B
Recent Raise
$66M
ShiraTronics develops a neuromodulation device for treating chronic migraine patients.
Focus Areas
Medical device
neuromodulation
migraine therapy
chronic migraine
FDA-approved
pivotal trial
Investors
